Sirnaomics cleared to start first trial of RNAi lead in cancer

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Aug 18, 2018 at 5:22 PM.

  1. #1 cafead, Aug 18, 2018 at 5:22 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,024
    Likes Received:
    3
    via Gene-silencing specialist Sirnaomics has been cleared to start trials of its STP705 drug in bile duct cancer, its first oncology indication.

    article source
     
    Quote

Reply to Thread